Publications by authors named "Jonathan M. Pitt"

Claim this Profile
I
Influenza vaccination in immunocompromised populations: Strategies to improve immunogenicity.
Freddy Caldera, Monica Mercer, Sandrine I Samson, Jonathan M Pitt, Mary S Hayney

Vaccine· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional profiling unveils type I and II interferon networks in blood and tissues across diseases.
Akul Singhania, Christine M Graham, Leona Gabryšová, Lúcia Moreira-Teixeira, Evangelos Stavropoulos, Jonathan M Pitt

Nat Commun· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenic and Non-immunogenic Cell Death in the Tumor Microenvironment.
Jonathan M Pitt, Guido Kroemer, Laurence Zitvogel

Adv Exp Med Biol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Tolerability of IncobotulinumtoxinA for Treating Glabellar Frown Lines in Korean Adults: A Postmarketing Observational Study.
Je-Young Park, Nak-Kwan Sung, Jonathan M Pitt

Dermatol Surg· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance.
Norma Bloy, Pauline Garcia, Céline M Laumont, Jonathan M Pitt, Antonella Sistigu

Immunol Rev· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The renaissance of anti-neoplastic immunity from tumor cell demise.
Yuting Ma, Jonathan M Pitt, Qingqing Li, Heng Yang

Immunol Rev· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy.
Laetitia Fend, Takahiro Yamazaki, Christelle Remy, Catherine Fahrner, Murielle Gantzer, Jonathan M Pitt

Cancer Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune biomarkers for prognosis and prediction of responses to immune checkpoint blockade in cutaneous melanoma.
Nicolas Jacquelot, Jonathan M Pitt, David P Enot, Maria Paula Roberti, Connie P M Duong

Oncoimmunology· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mouse models in oncoimmunology.
Laurence Zitvogel, Jonathan M Pitt, Romain Daillère, Mark J Smyth, Guido Kroemer

Nat Rev Cancer· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fine-Tuning Cancer Immunotherapy: Optimizing the Gut Microbiome.
Jonathan M Pitt, Marie Vétizou, Nadine Waldschmitt, Guido Kroemer, Mathias Chamaillard

Cancer Res· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Transcriptional Signatures in Response to Listeria monocytogenes Infection Reveals Temporal Changes That Result from Type I Interferon Signaling.
Jonathan M Pitt, Simon Blankley, Krzysztof Potempa, Christine M Graham, Lucia Moreira-Teixeira

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015.
Vashisht G. Y. Nanda, Weiyi Peng, Patrick Hwu, Michael A. Davies, Gennaro Ciliberto, Jonathan M. Pitt

J Transl Med· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors.
Jonathan M Pitt, Marie Vétizou, Romain Daillère, María Paula Roberti, Takahiro Yamazaki

Immunity· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy-induced microenvironmental changes in cancer.
Yuting Ma, Heng Yang, Jonathan M Pitt, Guido Kroemer, Laurence Zitvogel

J Mol Med (Berl)· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracellular vesicles: masters of intercellular communication and potential clinical interventions.
Jonathan M Pitt, Guido Kroemer, Laurence Zitvogel

J Clin Invest· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic cell-derived exosomes for cancer therapy.
Jonathan M Pitt, Fabrice André, Sebastian Amigorena, Jean-Charles Soria, Alexander Eggermont

J Clin Invest· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC.
Benjamin Besse, Mélinda Charrier, Valérie Lapierre, Eric Dansin, Olivier Lantz, Jonathan M Pitt

Oncoimmunology· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients.
Sylvie Rusakiewicz, Aurélie Perier, Michaela Semeraro, Jonathan M Pitt, Elke Pogge von Strandmann

Oncoimmunology· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma.
Nicolas Jacquelot, David P Enot, Caroline Flament, Nadège Vimond, Carolin Blattner, Jonathan M Pitt

J Clin Invest· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing the clinical coverage and anticancer efficacy of immune checkpoint blockade through manipulation of the gut microbiota.
Jonathan M Pitt, Marie Vétizou, Ivo Gomperts Boneca, Patricia Lepage, Mathias Chamaillard

Oncoimmunology· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.
Marie Vétizou, Jonathan M Pitt, Romain Daillère, Patricia Lepage, Nadine Waldschmitt

Science· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic cell-derived exosomes as immunotherapies in the fight against cancer.
Jonathan M Pitt, Mélinda Charrier, Sophie Viaud, Fabrice André, Benjamin Besse

J Immunol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination against tuberculosis: how can we better BCG?
Jonathan M Pitt, Simon Blankley, Helen McShane, Anne O'Garra

Microb Pathog· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of IL-10 signaling during bacillus Calmette-Guérin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-γ and IL-17 responses and increases protection to Mycobacterium tuberculosis infection.
Jonathan M Pitt, Evangelos Stavropoulos, Paul S Redford, Amy M Beebe, Gregory J Bancroft

J Immunol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis